Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Mycophenolate mofetil for relapsing-remitting multiple sclerosis.

Xiao Y, Huang J, Luo H, Wang J.

Cochrane Database Syst Rev. 2014 Feb 7;(2):CD010242. doi: 10.1002/14651858.CD010242.pub2. Review.

PMID:
24505016
2.

Teriflunomide for multiple sclerosis.

He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L.

Cochrane Database Syst Rev. 2016 Mar 22;3:CD009882. doi: 10.1002/14651858.CD009882.pub3. Review.

PMID:
27003123
3.

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.

Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G.

Cochrane Database Syst Rev. 2013 Jun 6;(6):CD008933. doi: 10.1002/14651858.CD008933.pub2. Review.

PMID:
23744561
4.

Fingolimod for relapsing-remitting multiple sclerosis.

La Mantia L, Tramacere I, Firwana B, Pacchetti I, Palumbo R, Filippini G.

Cochrane Database Syst Rev. 2016 Apr 19;4:CD009371. doi: 10.1002/14651858.CD009371.pub2. Review.

PMID:
27091121
5.

Natalizumab for relapsing remitting multiple sclerosis.

Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007621. doi: 10.1002/14651858.CD007621.pub2. Review.

PMID:
21975773
6.

Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.

La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A.

Cochrane Database Syst Rev. 2014 Jul 26;(7):CD009333. doi: 10.1002/14651858.CD009333.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 24;11:CD009333.

PMID:
25062935
7.

Alemtuzumab for multiple sclerosis.

Riera R, PorfĂ­rio GJ, Torloni MR.

Cochrane Database Syst Rev. 2016 Apr 15;4:CD011203. doi: 10.1002/14651858.CD011203.pub2. Review.

PMID:
27082500
8.

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Tramacere I, Del Giovane C, Salanti G, D'Amico R, Filippini G.

Cochrane Database Syst Rev. 2015 Sep 18;(9):CD011381. doi: 10.1002/14651858.CD011381.pub2. Review.

PMID:
26384035
9.

Rituximab for relapsing-remitting multiple sclerosis.

He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H.

Cochrane Database Syst Rev. 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. Review.

PMID:
24310855
10.

Daclizumab for relapsing remitting multiple sclerosis.

Liu J, Wang LN, Zhan S, Xia Y.

Cochrane Database Syst Rev. 2013 Dec 23;(12):CD008127. doi: 10.1002/14651858.CD008127.pub4. Review.

PMID:
24363032
11.

Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.

La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A.

Cochrane Database Syst Rev. 2016 Nov 24;11:CD009333. Review.

PMID:
27880972
12.

Teriflunomide for multiple sclerosis.

He D, Xu Z, Dong S, Zhang H, Zhou H, Wang L, Zhang S.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD009882.

PMID:
23235682
13.

Dimethyl fumarate for multiple sclerosis.

Xu Z, Zhang F, Sun F, Gu K, Dong S, He D.

Cochrane Database Syst Rev. 2015 Apr 22;(4):CD011076. doi: 10.1002/14651858.CD011076.pub2. Review.

PMID:
25900414
14.

Mitoxantrone for multiple sclerosis.

Martinelli Boneschi F, Vacchi L, Rovaris M, Capra R, Comi G.

Cochrane Database Syst Rev. 2013 May 31;(5):CD002127. doi: 10.1002/14651858.CD002127.pub3. Review.

PMID:
23728638
15.

Daclizumab for relapsing remitting multiple sclerosis.

Liu J, Wang L, Zhan SY, Xia Y.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD008127. doi: 10.1002/14651858.CD008127.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(12):CD008127.

PMID:
22513956
16.

Laquinimod for multiple sclerosis.

He D, Han K, Gao X, Dong S, Chu L, Feng Z, Wu S.

Cochrane Database Syst Rev. 2013 Aug 6;(8):CD010475. doi: 10.1002/14651858.CD010475.pub2. Review.

PMID:
23922214
17.

Interferon beta for secondary progressive multiple sclerosis.

La Mantia L, Vacchi L, Di Pietrantonj C, Ebers G, Rovaris M, Fredrikson S, Filippini G.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005181. doi: 10.1002/14651858.CD005181.pub3. Review.

PMID:
22258960
18.

Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis.

Goldberg LD, Edwards NC, Fincher C, Doan QV, Al-Sabbagh A, Meletiche DM.

J Manag Care Pharm. 2009 Sep;15(7):543-55.

19.

Rituximab for relapsing-remitting multiple sclerosis.

He D, Zhou H, Han W, Zhang S.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009130. doi: 10.1002/14651858.CD009130.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD009130.

PMID:
22161445
20.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110

Supplemental Content

Support Center